Apolipoprotein E Gene Polymorphism, Glycated Hemoglobin, and Peripheral Arterial Disease Risk in Chinese Type 2 Diabetic Patients

被引:8
作者
Hu, Yujing [1 ]
Ling, Tinghuan [1 ]
Yu, Min [1 ]
Bai, Yang [1 ]
Feng, Tongbao [1 ]
Zhang, Ping [1 ]
Wang, Yan [1 ]
机构
[1] Nanjing Med Univ, Affiliated Changzhou Peoples Hosp 2, Dept Clin Lab, Changzhou, Jiangsu, Peoples R China
关键词
ANKLE-BRACHIAL INDEX; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; PATHOPHYSIOLOGY; DYSFUNCTION; PREVALENCE; MORTALITY; DIAGNOSIS; PROFILES; GENOTYPE;
D O I
10.1155/2020/6040525
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. The apolipoprotein E (ApoE) gene polymorphism has been found to influence plasma lipid concentration, and its correlation with peripheral arterial disease (PAD) has been investigated. However, it is unclear whether ApoE is associated with PAD in Chinese type 2 diabetes mellitus (T2DM) patients. Therefore, our study is aimed at investigating the relationship between the ApoE gene polymorphism and PAD in Chinese T2DM patients. Methods. A total of 192 T2DM patients were divided into two groups: T2DM and T2DM with PAD. The clinical and biochemical parameters were obtained. Polymerase chain reaction was used to identify the genotypes of ApoE. The multivariable logistic regression analysis was used to identify the possible risk factor for PAD. Results. There were no significant differences in the genotype and allele frequencies of ApoE between the T2DM and T2DM with PAD groups. However, the T2DM with PAD group tended to have more epsilon 4/epsilon 3 genotypes (21.5% vs. 11.3%) than the T2DM group. The multivariate logistic regression showed that smoking, age, disease duration, TG, LDL, and HbA1c were risk factors for PAD. Conclusions. These results demonstrated that there was no evidence of a relationship between ApoE and PAD.
引用
收藏
页数:6
相关论文
共 37 条
[1]   Measurement and Interpretation of the Ankle-Brachial Index A Scientific Statement From the American Heart Association [J].
Aboyans, Victor ;
Criqui, Michael H. ;
Abraham, Pierre ;
Allison, Matthew A. ;
Creager, Mark A. ;
Diehm, Curt ;
Fowkes, F. Gerry R. ;
Hiatt, William R. ;
Joensson, Bjoern ;
Lacroix, Philippe ;
Marin, Benoit ;
McDermott, Mary M. ;
Norgren, Lars ;
Pande, Reena L. ;
Preux, Pierre-Marie ;
Stoffers, H. E. ;
Treat-Jacobson, Diane .
CIRCULATION, 2012, 126 (24) :2890-+
[2]   Dyslipidemia Profiles in Patients with Peripheral Artery Disease [J].
Aday, Aaron W. ;
Everett, Brendan M. .
CURRENT CARDIOLOGY REPORTS, 2019, 21 (06)
[3]  
Aday AW, 2018, CIRCULATION, V138, P2330, DOI [10.1161/CIRCULATIONAHA.118.034645, 10.1161/CIRCULATIONAHA.118.035432]
[4]   International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [J].
Bhatt, DL ;
Steg, PG ;
Ohman, EM ;
Hirsch, AT ;
Ikeda, Y ;
Mas, JL ;
Goto, S ;
Liau, CS ;
Richard, AJ ;
Röther, J ;
Wilson, PWF ;
Andersen-Dalheim, H ;
Anderson, P ;
Anell, B ;
Arber, S ;
Armstrong, K ;
Arnot, D ;
Baldam, A ;
Barratt, I ;
Barresi, S ;
Beder, J ;
Benson, M ;
Bergman, F ;
Best, J ;
Bhasim, R ;
Bovell, G ;
Bowman, N ;
Brkic, M ;
Bromberger, D ;
Brown, D ;
Brown, J ;
Brownstein, M ;
Bruce, A ;
Buonopane, J ;
Burns, S ;
Butler, A ;
Byrne, D ;
Carson, J ;
Cassimatis, P ;
Chaffey, G ;
Chambers, D ;
Chan, WJ ;
Chan, B ;
Cheatham, J ;
Chen, R ;
Cheong, B ;
Cheung, C ;
Chin, J ;
Chiu, A ;
Choo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02) :180-189
[5]   Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management [J].
Chapman, M. John ;
Ginsberg, Henry N. ;
Amarenco, Pierre ;
Andreotti, Felicita ;
Boren, Jan ;
Catapano, Alberico L. ;
Descamps, Olivier S. ;
Fisher, Edward ;
Kovanen, Petri T. ;
Kuivenhoven, Jan Albert ;
Lesnik, Philippe ;
Masana, Luis ;
Nordestgaard, Borge G. ;
Ray, Kausik K. ;
Reiner, Zeljko ;
Taskinen, Marja-Riitta ;
Tokgozoglu, Lale ;
Tybjaerg-Hansen, Anne ;
Watts, Gerald F. .
EUROPEAN HEART JOURNAL, 2011, 32 (11) :1345-1361
[6]   Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease [J].
Chaudhary, Rajesh ;
Likidlilid, Atip ;
Peerapatdit, Thavatchai ;
Tresukosol, Damras ;
Srisuma, Sorachai ;
Ratanamaneechat, Suphachai ;
Sriratanasathavorn, Charn .
CARDIOVASCULAR DIABETOLOGY, 2012, 11
[7]   Atherosclerotic Peripheral Vascular Disease Symposium II Executive Summary [J].
Creager, Mark A. ;
White, Christopher J. ;
Hiatt, William R. ;
Criqui, Michael H. ;
Josephs, Shellie C. ;
Alberts, Mark J. ;
Pearce, William H. ;
Gray, Bruce H. ;
Rocha-Singh, Krishna J. .
CIRCULATION, 2008, 118 (25) :2811-2825
[8]   Epidemiology of Peripheral Artery Disease [J].
Criqui, Michael H. ;
Aboyans, Victor .
CIRCULATION RESEARCH, 2015, 116 (09) :1509-1526
[9]   Apolipoprotein E Gene Polymorphism and Subclinical Carotid Atherosclerosis: The Northern Manhattan Study [J].
Doliner, Brett ;
Dong, Chuanhui ;
Blanton, Susan H. ;
Gardener, Hannah ;
Elkind, Mitchell S. V. ;
Sacco, Ralph L. ;
Demmer, Ryan T. ;
Desvarieux, Moise ;
Rundek, Tatjana .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (03) :645-652
[10]   Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review [J].
Eichner, JE ;
Dunn, ST ;
Perveen, G ;
Thompson, DM ;
Stewart, KE ;
Stroehla, BC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (06) :487-495